This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- DA Davidson analyst Brian Holland upgraded Utz Brands, Inc. (NYSE:UTZ) from Neutral to Buy and maintained the price target of $16. Utz Brands shares closed at $13.39 on Wednesday. See how other analysts view this stock.
- JP Morgan analyst Harlan Sur upgraded the rating for Cadence Design Systems, Inc. (NASDAQ:CDNS) from Neutral to Overweight and raised the price target from $300 to $325. Cadence Design Systems shares closed at $265.42 on Wednesday. See how other analysts view this stock.
- UBS analyst A.J. Rice upgraded Healthcare Services Group, Inc. (NASDAQ:HCSG) from Neutral to Buy and raised the price target from $12 to $15. Healthcare Services shares closed at $12.19 on Wednesday. See how other analysts view this stock.
- Piper Sandler analyst Adam Maeder upgraded the rating for Edwards Lifesciences Corporation (NYSE:EW) from Neutral to Overweight and raised the price target from $73 to $80. Edwards Lifesciences shares closed at $70.46 on Wednesday. See how other analysts view this stock.
- Raymond James analyst Michael Rose upgraded Renasant Corporation (NYSE:RNST) from Outperform to Strong Buy and maintained the price target of $40. Renasant shares closed at $31.11 on Wednesday. See how other analysts view this stock.
Considering buying EW stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Posted-In: top upgrades
